Trial intelligence / Profile preview

Aeris BLVR System in advanced emphysema

NCT00205907Phase 2Terminated

Sponsor
Aeris Therapeutics
Start
Jan 2005
Primary completion
Aug 2006
Modality
Hydrogel Systems
Countries
1
01

Overview

A Phase 2 trial of AeriSeal in pulmonary emphysema, sponsored by Aeris Therapeutics. Started Jan 2005; status: terminated.

02

Drugs

AeriSeal
03

Conditions

pulmonary emphysema

Beyond the preview

Go deeper on NCT00205907.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00205907.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call